We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Thermo Fisher Scientific Acquires Micro-Volume UV-Vis Instrumentation

By HospiMedica staff writers
Posted on 29 Oct 2007
Thermo Fisher Scientific, Inc. More...
(Waltham, MA, USA) has acquired NanoDrop Technologies, LLC (Wilmington, DE, USA), a manufacturer of microvolume ultraviolet visible (UV-Vis) instrumentation.

The acquisition will strengthen Thermo Fisher's range of UV-Vis spectrophotometry instruments for applications involving small sample volumes. For example, micro-volume samples are used in emerging life sciences research that involves measurement of DNA and proteins. NanoDrop, has annual revenues of approximately US$35 million.

"Growing demand from our laboratory customers to accelerate sample preparation time is now compounded by the need to work with smaller sample sizes,” said Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. "NanoDrop's patented technologies uniquely allow customers to quickly and easily analyze difficult microvolume samples without the need for dilution. This preserves precious samples to greatly increase laboratory productivity.”

NanoDrop currently produces three products--the NanoDrop ND-1000 and ND-8000 UV-Vis spectrophotometers and the NanoDrop ND-3300 fluorescence spectrophotometer. The ND-1000 is a full-spectrum UV-Vis spectrophotometer used to quantify nucleic acids, proteins, fluorescent dyes, and other compounds. The ND-8000 is also a full-spectrum UV-Vis spectrophotometer that can measure eight samples at a time, permitting measurement of 96 samples in five minutes. The ND-3300 is a versatile fluorometer with broad excitation range that enables the use of microreactions for quantitation of limited mass. These instruments are highly versatile tools that are suitable for a wide variety of laboratories and uses, including life-sciences research and industrial applications.

The NanoDrop product line will be integrated into Thermo Fisher's scientific instruments business, part of its Analytical Technologies Segment, and will be marketed under the company's Thermo Scientific technology brand.


Related Links:
Thermo Fisher Scientific Inc
NanoDrop Technologies

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.